Dr. Lai specializes in detecting, monitoring, and treating acute leukemia in adults. Previously at the National Cancer Institute (NCI) at the National Institutes of Health (NIH), she focused on clinical trials in acute leukemias and lymphomas. Under Dr. Lai’s leadership, the leukemia program at the Lombardi Comprehensive Cancer Center offers acute leukemia patients advanced and highly specialized care, including clinical trials with novel agents and immunotherapy. Dr. Lai’s clinical expertise complements a multidisciplinary team of specialists dedicated to MedStar Georgetown’s Stem Cell Transplant and Cellular Immunotherapy Program. Dr. Lai’s research focuses on novel therapeutics, designing and conducting clinical trials, and health outcomes for leukemia patients.